The nephrotic syndrome;Das nephrotische syndrom

Internist

Volumn 39, Issue 12, 1998, Pages 1246-1252

  Orth, S R ^a,b   Ritz, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Sektion Nephrologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EDEMA; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HYPERLIPIDEMIA; KIDNEY FAILURE; NEPHROTIC SYNDROME; PROTEINURIA; REVIEW; THROMBOEMBOLISM;

ADULT; CHILD; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; NEPHROTIC SYNDROME;

EID: 0032445917     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080050297     Document Type: Review

References (36)

1. Al Bander H, Kaysen GA (1991) Ineffectiveness of dietary protein augmentation in the management of the nephrotic syndrome. Pediatr Nephrol 5:482-486
2. Ambalavanan S, Fauvel J-P, Sibley RK, Myers BD (1996) Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J Am Soc Nephrol 7:290-298
3. Andrassy K, Ritz E, Bommer J (1980) Hypercoagulability in the nephrotic syndrome. Klin Wochenschr Med 58:1029-1036
4. Arisz L, Donker AJM, Brentjens JRH, van der Hem GK (1976) The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med Scand 199:121-125
5. Beaufils F, Schlegel N, Loirat C, Marotte R, Pillion G, Mathieu H (1985) Urokinase treatment of pulmonary artery thrombosis complicating the pediatric nephrotic syndrome. Crit Care Med 13:132-134
6. Bellomo R, Atkins RC (1993) Membranous nephropathy and thromboembolism: Is prophylactic anticoagulation warranted? Nephron 63:249-254
7. Cameron JS (1987) The nephrotic syndrome and its complications. Am J Kidney Dis 10:157-171
8. D'Amico G, Gentile MG, Manna G, Fellin G, Ciceri R, Cofano F, Petrini C, Lavarda F, Perolini S, Porrini M (1992) Effect of vegeterian soy diet on hyperlipidaemia in nephrotic syndrome. Lancet 339:1131-1134
9. Fliser D, Schröter M, Neubeck M, Ritz E (1994) Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 46:482-488
10. Gansevoort RT, de Zeeuw D, de Jong PE (1993) Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney Int 44:579-584
11. Gansevoort RT, de Zeeuw D, de Jong PE (1995) Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal disease. Nephrol Dial Transplant 10:497-504
12. Gansevoort RT, Heeg JE, Dikkeschei FD, de Zeeuw D, de Jong PE, Dullaart RPF (1994) Symptomatic antiproteinuric treatment decreases serum lipoprotein (a) concentration in patients with glomerular proteinuria. Nephrol Dial Transplant 9:244-250
13. Gansevoort RT, Sluiter WJ, Hemmelder MH, de Zeeuw D, de Jong PE ( 1995) Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963-1974
14. Haas M, Meehan SM, Karrison TG, Spargo BH (1997) Changing etiologies of adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 30:621-631
15. Hall AV, Parbtani A, Clark WF, Spanner E, Huff MW, Philbrick DJ, Holub BJ (1992) Omega-3 fatty acid supplementation in primary nephrotic syndrome: Effects on plasma lipids and coagulopathy. J Am Soc Nephrol 3:1321-1329
16. Haws RM, Baum M (1993) Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 91:1142-1146
17. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D (1989) Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int 36:272-279
18. Hemmelder MH, de Zeeuw D, Gansevoort RT, de Jong PE (1996) Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition. Kidney Int 49:174-180
19. Jones CL, Hebert D (1991) Pulmonary thromboembolism in the nephrotic syndrome. Pediatr Nephrol 5:56-58
20. Joven J, Villabona C, Vilella E, Masana L, Alberti R, Vallés M (1990) Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 323:579-584
21. Koomans HA, Boer WH, Dorhout Mees EJ (1987) Renal function during recovery from minimal lesion nephrotic syndrome. Nephron 47:173-178
22. Korbet SM (1998) Primary focal segmental glomerulosclerosis. J Am Soc Nephrol 9:1333-1340
23. Llach F, Papper S, Massry SG (1980) The clinical spectrum of renal vein thrombosis: Acute and chronic. Am J Med 69:819-827
24. Ordoñez JD, Hiatt RA, Killebrew EJ, Fireman BH (1993) The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int 44:638-642
25. Orth SR, Ritz E (1998) The nephrotic syndrome. N Engl J Med 338:1202-1211
26. Orth SR, Ritz E, Schrier RW (1997) The renal risks of smoking. Kidney Int 51:1669-1677
27. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redaelli B, Grassi C, Pozzi C, Bizzarri D, Banfi G (1995) A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48:1600-1604
28. Remuzzi G, Ruggenenti P, Benigni A (1997) Understanding the nature of renal disease progression. Kidney Int 51:2-15
29. Robert A, Olmer M, Sampol J, Gugliotta JE, Casanova P (1987) Clinical correlation between hypercoagulability and thromboembolic phenomena. Kidney Int 31:830-835
30. Sarasin FP, Schifferli JA (1994) Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int 45:578-585
31. Spitalewitz S, Porush JG, Cattran D, Wright N (1993) Treatment of hyperlipidemia in the nephrotic syndrome: The effects of pravastatin therapy. Am J Kidney Dis 22:143-150
32. Thomas ME, Harris KPG, Ramaswamy C, Hattersley JM, Wheeler DC, Varghese Z, Williams JD, Walls J, Moorhead JF (1993) Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 44:1124-1129
33. Vande Walle JG, Donckerwolcke RAMG, van Isselt JW, Derkx FHM, Joles JA, Koomans HA (1995) Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 346:148-152
34. Vande Walle JG, Donckerwolcke RAMG, Wimersma Greidanus TB, Joles JA, Koomans HA (1996) Renal sodium handling in children with nephrotic relapse: relation to hypovolaemic symptoms. Nephrol Dial Transplant 11:2202-2208
35. Weidmann P, Boehlen LM, deCourten M (1993) Effects of different antihypertensive drugs on human diabetic proteinuria. Nephrol Dial Transplant 8:582-584
36. Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Freidman PA, Souney PF (1983) Response of the kidney to furosemide. I: effects of salt intake and renal compensation. J Lab Clin Med 102:450-458